510(k) Report

510(k) · Cleared

Cleared

Excel Photic Stimulator, Model (XLPS-1)

K991903510(k) TraditionalCleared Aug 4, 199961-day reviewClass II21 CFR 882.1890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Excel Tech., Ltd. · GWE Stimulator, Photic, Evoked Response

Cleared on Aug 4, 1999 after a 61-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Aug 4, 1999
Review
61 days
Class
Class II
Product code
GWE
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K991903Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWE device

  1. #1 K211643 Vision Monitor - MonpackONEscore 5.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All GWE devices

GWE Stimulator, Photic, Evoked Response: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GWE

2in 2022

2009: 12010: 12011: 12012: 22015: 12018: 12020: 12021: 22022: 2
2007high 2 (2012) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWE

Too few GWE 510(k)s in any year since 2007 to give a median.

Recalls per year · GWE

1in 2015

2007: 12015: 1
2007high 1 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GWE

1in 2025

2008: 12010: 12012: 12014: 12016: 22018: 22022: 22025: 1
2007high 2 (2016) · low 0 (2007)2025

MAUDE reports naming product code GWE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—10
20080—01
20091—00
20101—01
20111—00
20122—01
20130—00
20140—01
20151—10
20160—02
20170—00
20181—02
20190—00
20201—00
20212—00
20222—02
20230—00
20240—00
20250—01
20260—0—

What is it indicated for?

The Excel Photic Stimulator is intended for epileptic activation of the EEG in suspected epileptic seizures.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K991903: Excel Photic Stimulator, Model (XLPS-1).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K991903

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026